FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034289621> ?p ?o ?g. }

• W2034289621 endingPage "3617" @default.
• W2034289621 startingPage "3611" @default.
• W2034289621 abstract "There is little consensus regarding the most appropriate dose regimen for radioiodine (131I) in the treatment of hyperthyroidism. We audited 813 consecutive hyperthyroid patients treated with radioiodine to compare the efficacy of 2 fixed-dose regimens used within our center (185 megabequerels, 370 megabequerels) and to explore factors that may predict outcome. Patients were categorized into 3 diagnostic groups: Graves' disease, toxic nodular goiter, and hyperthyroidism of indeterminate etiology. Cure after a single dose of 131I was investigated and defined as euthyroid off all treatment for 6 months or T4 replacement for biochemical hypothyroidism in all groups. As expected, patients given a single dose of 370 megabequerels had a higher cure rate than those given 185 megabequerels, (84.6% vs. 66.6%, P < 0.0001) but an increase in hypothyroidism incidence at 1 yr (60.8% vs. 41.3%, P < 0.0001). There was no difference in cure rate between the groups with Graves' disease and those with toxic nodular goiter (69.5% vs. 71.4%; P, not significant), but Graves' patients had a higher incidence of hypothyroidism (54.5% vs. 31.7%, P < 0.0001). Males had a lower cure rate than females (67.6% vs. 76.7%, P = 0.02), whereas younger patients (<40 yr) had a lower cure rate than patients over 40 yr old (68.9% vs. 79.3%, P < 0.001). Patients with more severe hyperthyroidism (P < 0.0001) and with goiters of medium or large size (P < 0.0001) were less likely to be cured after a single dose of 131I. The use of antithyroid drugs, during a period 2 wk before or after 131I, resulted in a significant reduction in cure rate in patients given 185 megabequerels 131I (P < 0.01) but not 370 megabequerels. Logistic regression analysis showed dose, gender, goiters of medium or large size, and severity of hyperthyroidism to be significant independent prognostic factors for cure after a single dose of 131I. We have demonstrated that a single fixed dose of 370 megabequerels 131I is highly effective in curing toxic nodular hyperthyroidism as well as Graves' hyperthyroidism. Because male patients and those with more severe hyperthyroidism and medium or large-sized goiters are less likely to respond to a single dose of radioiodine, we suggest that the value of higher fixed initial doses of radioiodine should be evaluated in these patient categories with lower cure rates." @default.
• W2034289621 created "2016-06-24" @default.
• W2034289621 creator A5005436751 @default.
• W2034289621 creator A5049719396 @default.
• W2034289621 creator A5057139017 @default.
• W2034289621 creator A5076586050 @default.
• W2034289621 creator A5081480254 @default.
• W2034289621 date "2001-08-01" @default.
• W2034289621 modified "2023-09-29" @default.
• W2034289621 title "Radioiodine Treatment of Hyperthyroidism—Prognostic Factors for Outcome" @default.
• W2034289621 cites W1922525852 @default.
• W2034289621 cites W1982607912 @default.
• W2034289621 cites W1983363344 @default.
• W2034289621 cites W1986813772 @default.
• W2034289621 cites W2008453353 @default.
• W2034289621 cites W2015263663 @default.
• W2034289621 cites W2016462394 @default.
• W2034289621 cites W2023650482 @default.
• W2034289621 cites W2032270156 @default.
• W2034289621 cites W2038217607 @default.
• W2034289621 cites W2043675051 @default.
• W2034289621 cites W2046116343 @default.
• W2034289621 cites W2064969958 @default.
• W2034289621 cites W2081799769 @default.
• W2034289621 cites W2086890388 @default.
• W2034289621 cites W2102272507 @default.
• W2034289621 cites W2114929242 @default.
• W2034289621 cites W2114947422 @default.
• W2034289621 cites W2133547068 @default.
• W2034289621 cites W2144841775 @default.
• W2034289621 cites W2145066704 @default.
• W2034289621 cites W2145791055 @default.
• W2034289621 cites W2148113299 @default.
• W2034289621 cites W2163387976 @default.
• W2034289621 cites W2171587699 @default.
• W2034289621 cites W2314427644 @default.
• W2034289621 cites W2418063219 @default.
• W2034289621 doi "https://doi.org/10.1210/jcem.86.8.7781" @default.
• W2034289621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11502786" @default.
• W2034289621 hasPublicationYear "2001" @default.
• W2034289621 type Work @default.
• W2034289621 sameAs 2034289621 @default.
• W2034289621 citedByCount "114" @default.
• W2034289621 countsByYear W20342896212012 @default.
• W2034289621 countsByYear W20342896212013 @default.
• W2034289621 countsByYear W20342896212014 @default.
• W2034289621 countsByYear W20342896212015 @default.
• W2034289621 countsByYear W20342896212016 @default.
• W2034289621 countsByYear W20342896212017 @default.
• W2034289621 countsByYear W20342896212018 @default.
• W2034289621 countsByYear W20342896212019 @default.
• W2034289621 countsByYear W20342896212020 @default.
• W2034289621 countsByYear W20342896212021 @default.
• W2034289621 countsByYear W20342896212022 @default.
• W2034289621 countsByYear W20342896212023 @default.
• W2034289621 crossrefType "journal-article" @default.
• W2034289621 hasAuthorship W2034289621A5005436751 @default.
• W2034289621 hasAuthorship W2034289621A5049719396 @default.
• W2034289621 hasAuthorship W2034289621A5057139017 @default.
• W2034289621 hasAuthorship W2034289621A5076586050 @default.
• W2034289621 hasAuthorship W2034289621A5081480254 @default.
• W2034289621 hasBestOaLocation W20342896211 @default.
• W2034289621 hasConcept C120665830 @default.
• W2034289621 hasConcept C121332964 @default.
• W2034289621 hasConcept C126322002 @default.
• W2034289621 hasConcept C134018914 @default.
• W2034289621 hasConcept C137627325 @default.
• W2034289621 hasConcept C2776254400 @default.
• W2034289621 hasConcept C2776652619 @default.
• W2034289621 hasConcept C2777195454 @default.
• W2034289621 hasConcept C2779134260 @default.
• W2034289621 hasConcept C2781413609 @default.
• W2034289621 hasConcept C2994123057 @default.
• W2034289621 hasConcept C526584372 @default.
• W2034289621 hasConcept C61511704 @default.
• W2034289621 hasConcept C71315377 @default.
• W2034289621 hasConcept C71924100 @default.
• W2034289621 hasConcept C90924648 @default.
• W2034289621 hasConceptScore W2034289621C120665830 @default.
• W2034289621 hasConceptScore W2034289621C121332964 @default.
• W2034289621 hasConceptScore W2034289621C126322002 @default.
• W2034289621 hasConceptScore W2034289621C134018914 @default.
• W2034289621 hasConceptScore W2034289621C137627325 @default.
• W2034289621 hasConceptScore W2034289621C2776254400 @default.
• W2034289621 hasConceptScore W2034289621C2776652619 @default.
• W2034289621 hasConceptScore W2034289621C2777195454 @default.
• W2034289621 hasConceptScore W2034289621C2779134260 @default.
• W2034289621 hasConceptScore W2034289621C2781413609 @default.
• W2034289621 hasConceptScore W2034289621C2994123057 @default.
• W2034289621 hasConceptScore W2034289621C526584372 @default.
• W2034289621 hasConceptScore W2034289621C61511704 @default.
• W2034289621 hasConceptScore W2034289621C71315377 @default.
• W2034289621 hasConceptScore W2034289621C71924100 @default.
• W2034289621 hasConceptScore W2034289621C90924648 @default.
• W2034289621 hasIssue "8" @default.
• W2034289621 hasLocation W20342896211 @default.
• W2034289621 hasLocation W20342896212 @default.
• W2034289621 hasOpenAccess W2034289621 @default.

• next